Valeo Pharma to Present at 2019 Bloom Burton & Co. Healthcare Investor Conference

MONTREAL, April 25, 2019 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH), a Canadian specialty pharmaceutical company dedicated to commercializing innovative prescription products, is pleased to announce that it will be  presenting  at the Bloom Burton & Co. Healthcare Investor Conference to be held April 30-May 1, 2019 in Toronto, Ontario.

Steve Saviuk, Valeo Pharma's Chief Executive Officer, will present a corporate update and an overview of Valeo Pharma's areas of therapeutic focus, Neurology, Oncology, Women's Health and Hospital products. Valeo's management team  will be available for one-on-one investor meetings on both conference days.

Presentation details are as follows:

• Date: Wednesday May 1^st, 2019
• Time: 4:00pm ET
• Location: Metro Toronto Convention Centre, 255 Front St W, Toronto, Ontario

About the Conference:
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.

About Bloom Burton & Co.
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).

About Valeo Pharma
Valeo Pharma is a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada. With a focus on Neurodegenerative Diseases, Oncology, Women's Health and Hospital products, Valeo Pharma has a growing portfolio of innovative products and a platform to properly manage these products through all stages of commercialization.  Headquartered in Kirkland, Quebec, Valeo Pharma has all capabilities internally to register and market health care solutions for Canadian patients. For more information, please visit www.valeopharma.com

SOURCE Valeo Pharma inc.

For further information: Valeo Pharma, Steve Saviuk - President and CEO, Phone : [phone], Email : [e-mail]; Luc Mainville - Senior VP and CFO, Phone : [phone], Email : [e-mail]

Related Links

http://www.valeopharma.com